Godavari Drugs Ltd.

BSE: GODAVARI530317ISIN INE362C01012

Healthcare
Pharmaceuticals

BSE listing

Share price

₹112.25+2.30 (+2.09%)

as of 18 Sep 2026

52W high: ₹135.25
52W low: ₹69.70
Off 52W high: -17.01%
1M return: +10.10%
3M return: -5.71%
6M return: +35.32%
1Y return: +31.44%
20D avg volume: 12,760
50 DMA: ₹108.51
200 DMA: ₹101.65

Key ratios Standalone

Market cap: ₹113.68 Cr
Current price: ₹112.25
52W high / low: ₹135.25 / ₹69.70
Face value: ₹10.00
P/E: 27.31
P/B: 2.73
EPS (TTM): ₹4.11
Book value / share: ₹41.12
ROE: 9.98%
ROCE: 7.80%
Operating margin: 9.54%
Net margin: 3.97%
Debt / equity: 1.01
Net debt: ₹61.85 Cr
Interest cover: 2.27
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 189.5 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	27.96	33.16	22.18	26.65	23.81	25.50	—
	0.15	0.14	0.02	0.64	0.01	0.11	—
	26.93	31.79	21.43	26.16	22.52	24.17	—
	26.15	30.27	16.64	23.99	17.99	21.73	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	1.48	1.32	1.58	1.44	1.36	1.40	—
	0.90	0.96	1.11	0.91	1.00	1.11	—
	0.59	0.61	0.61	0.60	0.60	0.67	—
	4.16	3.53	3.25	3.10	2.42	3.39	—
	1.18	1.51	0.77	1.12	1.30	1.44	—
	0.00	0.10	0.25	0.00	0.00	0.00	—
	1.18	1.62	1.02	1.12	1.30	1.44	—
	0.07	0.33	0.26	0.12	0.26	0.55	—
	1.11	1.29	0.76	1.00	1.04	0.89	—
	1.10	1.71	1.01	1.33	1.38	1.19	—
Key metrics
	2.67	3.19	2.74	2.63	2.90	3.22	—
	9.50%	9.60%	12.40%	9.90%	12.20%	12.60%	—
	4.00%	3.90%	3.40%	3.80%	4.40%	3.50%	—
	—	2.20%	—	2.60%	—	3.60%	—
	17.40%	30.00%	—	—	—	—	—
	6.70%	44.90%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	109.95	105.81	113.35	—
	0.95	0.81	0.98	—
	106.31	101.91	108.70	—
	97.05	88.89	85.24	—
	0.00	0.00	0.00	—
	5.82	5.70	5.03	—
	3.88	3.98	4.73	—
	2.41	2.43	2.45	—
	14.04	12.30	14.84	—
	4.58	4.71	5.63	—
	0.35	0.36	0.00	—
	4.94	5.06	5.63	—
	0.78	0.97	1.25	—
	4.16	4.09	4.38	—
	5.15	5.43	5.82	—
Key metrics
	11.23	11.47	12.81	—
	10.21%	10.80%	11.30%	—
	3.78%	3.90%	3.90%	—
	—	7.80%	14.80%	—
	—	-6.70%	—	—
	—	-6.60%	—	—
	—	-25.99	-8.80	—
	—	0.18	2.56	—
	—	1.01	1.42	—
	—	61.85	59.26	—
	—	189.5	133.9	—
Balance sheet
	—	200.43	143.08	—
	—	111.80	78.76	—
	—	14.51	2.37	—
	—	43.58	42.32	—
	—	46.06	27.94	—
	—	—	5.10	—
	—	30.31	32.61	—
	—	34.71	28.71	—
	—	85.14	73.09	—
	—	76.36	61.63	—
	—	39.39	37.73	—
	—	36.97	23.90	—
	—	75.80	43.35	—
Cash flow
	—	0.73	11.20	—
	—	-25.95	-19.51	—
	—	37.35	8.07	—
	—	26.72	20.00	—

Compounded growth

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 40.23%

Holder	Type	Holding	Previous	Change
SUSHMA KAKANI	Promoter	11.40%	—	—
KAMALA JAJU	Promoter	8.99%	—	—
MOHIT JAJU	Promoter	5.28%	—	—
MUKUND KAKANI	Promoter	3.46%	—	—
GHANSHYAM JAJU	Promoter	3.46%	—	—
AKSHEIT KAKANI	Promoter	3.22%	—	—
SURYATEJ ADVISORS LLP	Public	2.22%	—	—
SACHIN KASERA	Public	2.22%	—	—
HIGHCRESTT GLOBAL COMPANY LTD	Public	1.97%	—	—
PRIYANKA JAJU	Promoter	1.83%	—	—
KETAN V THAKKAR	Public	1.66%	—	—
UMESH KUMAR GUPTA	Public	1.40%	—	—
TANUSHREE KAKANI	Promoter	1.38%	—	—
MONEYBEE INVESTMENT TRUST - FLYINGBEE INVESTMENT FUND	Public	1.26%	—	—
Yash Surana	Public	1.11%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

We hereby inform that the company has dispatched a physical letter to the shareholders whose email addresses are not registered with the company/RTA/Depositories/DP. The Letter contains ....3 Sep 2026 · Company Update / General
Newspaper Publication for the 38th Annual General Meeting and E-Voting Instructions3 Sep 2026 · Company Update / Newspaper Publication
The Company informed that the 38th AGM of the Company is scheduled to be held on Friday, the 25th Sep 2026 at 03.00 pm through Video Conferencing/ other Audio Visual means in accordance ....1 Sep 2026 · Others / Reg. 34 (1) Annual Report
Notice of 38th AGM to be held on 25th Sep 2026 at 03.00 p.m. through Video Conferencing/Other Audio Visual Means in accordance with the relevant circulars issued by the MCA and SEBI.1 Sep 2026 · AGM/EGM / AGM
The Register of Members and Share Transfer Books of the Company will remain closed from 19.09.2026 to 25.09.2026 (Both days Inclusive) for taking record of the Members of the Company for ....1 Sep 2026 · Corp. Action / Book Closure
Amendment to MOA of the company was approved by Board of Directors. The Proposed change in MOA of the company is subject to necessary approvals from Ministry of Corporate Affairs, Shareholders ....1 Sep 2026 · Company Update / Amendments to Memorandum & Articles of Association
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we inform that the Board of Directors at its meeting held on 31st August, 2026 approved the following: 1. Alteration of the ....31 Aug 2026 · Others / Outcome without intimation
Submission of Statement on Deviation or Variation in uitilisation of Funds for the quarter ended 30 june 202617 Aug 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
Newspaper Publication of Unaudited Results for quarter ended 30.06.202617 Aug 2026 · Company Update / Newspaper Publication
Board of Directors of the Company in its meeting held on Friday, 14th August, 2026 at 11.45 A.M. approved and passed the resolution for allotment of Equity Shares on conversion of 7,86,690 ....14 Aug 2026 · Company Update / Allotment of Equity Shares
Submission of Un-Audited Standalone Financial Results for the Quarter ended as on June 30, 202614 Aug 2026 · Result / Financial Results
Submission of Un-Audited Standalone Financial Results for the Quarter ended as on June 30, 2026 and Allotment of Equity Shares on conversion of 7,86,690 (Seven Lakhs Eighty-Six Thousand ....14 Aug 2026 · Board Meeting / Outcome of Board Meeting
Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Update on board meeting - Intimation ....11 Aug 2026 · Board Meeting / Board Meeting
Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve the Un-audited Financial Results ....10 Aug 2026 · Board Meeting / Board Meeting
Certificate under Regulation 74(5) of SEBI (Depository and Participants) Regulations, 201811 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation of Closure of Trading window for the quarter ended June 30, 202623 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Please find the enclosed newspaper publication for your information28 May 2026 · Company Update / Newspaper Publication
Refer Enclosed27 May 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
Company in its Board Meeting has approved financial results for period ended 31st march, 202627 May 2026 · Result / Financial Results
We are enclosing Audited Financial Results for the Quarter ended 31st march , 2026 which are approved in Board Meeting which was held today i.e Wednesday, 27th Day of May, 202627 May 2026 · Board Meeting / Outcome of Board Meeting
Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve the financial results for the ....22 May 2026 · Board Meeting / Board Meeting
Annual Secretarial Compliance Report for the year ended 31st March, 202620 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Reply to the BSE Query seeking Clarification on Price Movement18 Apr 2026 · Company Update / General
The Exchange has sought clarification from Godavari Drugs Ltd on April 17, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....17 Apr 2026 · Company Update / Clarification
Please find enclosed herewith intimation under Regulation 74(5) of SEBI (DP) Regulations, 2015 for quarter ended March, 20268 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Priyanka Jaju, Mukund Kakani, Prashant Shrimal, ....23 Mar 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prashant Shrimal23 Mar 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Intimation of Trading Window Closure23 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mohit Jaju20 Mar 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kamala Jaju20 Mar 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Tanushree Kakani20 Mar 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Priyanka Jaju20 Mar 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aksheit Kakani20 Mar 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sushma Kakani20 Mar 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ieshir Jaju20 Mar 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mukund Kakani20 Mar 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ghanshyam Jaju20 Mar 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Outcome of the Board Meeting held on 18.03.202618 Mar 2026 · Others / Outcome without intimation
Disclosure under Regulation 44 (3) of SEBI (LODR) Regulations, 201512 Feb 2026 · AGM/EGM / EGM
Outcome of the EGM held on 12.02.202612 Feb 2026 · AGM/EGM / EGM

Board meetings

14 Aug 2026 Board Meeting - Financial Results